OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Clinical outcomes of COVID-19 in patients with sickle cell disease and sickle cell trait: A critical appraisal of the literature
Wouter S. Hoogenboom, Tharun T. Alamuri, Daniel M. McMahon, et al.
Blood Reviews (2021) Vol. 53, pp. 100911-100911
Open Access | Times Cited: 41
Wouter S. Hoogenboom, Tharun T. Alamuri, Daniel M. McMahon, et al.
Blood Reviews (2021) Vol. 53, pp. 100911-100911
Open Access | Times Cited: 41
Showing 1-25 of 41 citing articles:
Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000–2021: a systematic analysis from the Global Burden of Disease Study 2021
Azalea M Thomson, Theresa A. McHugh, Assaf P. Oron, et al.
The Lancet Haematology (2023) Vol. 10, Iss. 8, pp. e585-e599
Open Access | Times Cited: 237
Azalea M Thomson, Theresa A. McHugh, Assaf P. Oron, et al.
The Lancet Haematology (2023) Vol. 10, Iss. 8, pp. e585-e599
Open Access | Times Cited: 237
Hospital admissions linked to SARS-CoV-2 infection in children and adolescents: cohort study of 3.2 million first ascertained infections in England
Harrison Wilde, Christopher Tomlinson, Bilal A. Mateen, et al.
BMJ (2023), pp. e073639-e073639
Open Access | Times Cited: 21
Harrison Wilde, Christopher Tomlinson, Bilal A. Mateen, et al.
BMJ (2023), pp. e073639-e073639
Open Access | Times Cited: 21
COVID-19 in patients with anemia and haematological malignancies: risk factors, clinical guidelines, and emerging therapeutic approaches
Sareh Kakavandi, Bahareh Hajikhani, Paniz Azizi, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Sareh Kakavandi, Bahareh Hajikhani, Paniz Azizi, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Determinants of severity in sickle cell disease
David C. Rees, Valentine Brousse, John Brewin
Blood Reviews (2022) Vol. 56, pp. 100983-100983
Open Access | Times Cited: 34
David C. Rees, Valentine Brousse, John Brewin
Blood Reviews (2022) Vol. 56, pp. 100983-100983
Open Access | Times Cited: 34
Risk Factors for Pediatric Critical COVID-19: A Systematic Review and Meta-Analysis
Camila Aparicio, Zachary Willis, Mari Nakamura, et al.
Journal of the Pediatric Infectious Diseases Society (2024) Vol. 13, Iss. 7, pp. 352-362
Open Access | Times Cited: 4
Camila Aparicio, Zachary Willis, Mari Nakamura, et al.
Journal of the Pediatric Infectious Diseases Society (2024) Vol. 13, Iss. 7, pp. 352-362
Open Access | Times Cited: 4
Management of the Sickle Cell Trait: An Opinion by Expert Panel Members
Valeria Pinto, Lucia De Franceschi, Barbara Gianesin, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 10, pp. 3441-3441
Open Access | Times Cited: 9
Valeria Pinto, Lucia De Franceschi, Barbara Gianesin, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 10, pp. 3441-3441
Open Access | Times Cited: 9
Plasma Levels of Acyl-Carnitines and Carboxylic Acids Correlate With Cardiovascular and Kidney Function in Subjects With Sickle Cell Trait
Travis Nemkov, Sarah Skinner, Mor Diaw, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 15
Travis Nemkov, Sarah Skinner, Mor Diaw, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 15
Impact of the SARS-CoV-2 infection in individuals with sickle cell disease: an integrative review
Laura Resende Guimarães Pereira, Maria Vitoria Gomes da Silva, Carla Maria Ramos Germano, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 8
Laura Resende Guimarães Pereira, Maria Vitoria Gomes da Silva, Carla Maria Ramos Germano, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 8
Long‐term clinical outcomes and healthcare utilization of sickle cell disease patients with COVID ‐19: A 2.5‐year follow‐up study
Avery Feit, Moshe Gordon, Tharun T. Alamuri, et al.
European Journal Of Haematology (2023) Vol. 111, Iss. 4, pp. 636-643
Closed Access | Times Cited: 8
Avery Feit, Moshe Gordon, Tharun T. Alamuri, et al.
European Journal Of Haematology (2023) Vol. 111, Iss. 4, pp. 636-643
Closed Access | Times Cited: 8
Impact of SARS‐CoV‐2 infection on pain crisis and acute chest syndrome in patients with sickle cell anemia: A retrospective multi‐cohort study based on US national data from 2020 to 2022
Juan Alvarado, Keval Yerigeri, Anita Boakye, et al.
eJHaem (2024) Vol. 5, Iss. 2, pp. 299-307
Open Access | Times Cited: 2
Juan Alvarado, Keval Yerigeri, Anita Boakye, et al.
eJHaem (2024) Vol. 5, Iss. 2, pp. 299-307
Open Access | Times Cited: 2
COVID-19 Infection and Outcomes in Newborn Screening Cohorts of Sickle Cell Trait and Sickle Cell Disease in Michigan and Georgia
Susan Paulukonis, Angela Snyder, Matthew Smeltzer, et al.
Journal of Pediatric Hematology/Oncology (2023) Vol. 45, Iss. 4, pp. 174-180
Open Access | Times Cited: 6
Susan Paulukonis, Angela Snyder, Matthew Smeltzer, et al.
Journal of Pediatric Hematology/Oncology (2023) Vol. 45, Iss. 4, pp. 174-180
Open Access | Times Cited: 6
COVID-19 outcomes in patients with sickle cell disease and sickle cell trait compared with individuals without sickle cell disease or trait: a systematic review and meta-analysis
Isabella Michelon, Maysa Vilbert, Isabella Silveira Pinheiro, et al.
EClinicalMedicine (2023) Vol. 66, pp. 102330-102330
Open Access | Times Cited: 5
Isabella Michelon, Maysa Vilbert, Isabella Silveira Pinheiro, et al.
EClinicalMedicine (2023) Vol. 66, pp. 102330-102330
Open Access | Times Cited: 5
Immunogenicity of The BNT162b2 COVID-19 mRNA and ChAdOx1 nCoV-19 Vaccines in Patients with Hemoglobinopathies
Osman Radhwi, Hamza Jan, Abdullah Waheeb, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 151-151
Open Access | Times Cited: 9
Osman Radhwi, Hamza Jan, Abdullah Waheeb, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 151-151
Open Access | Times Cited: 9
Emergency department utilization before and during the COVID-19 pandemic among individuals with sickle cell disease
Brandon K. Attell, Allison P. Plaxco, Mei Zhou, et al.
BMC Emergency Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Brandon K. Attell, Allison P. Plaxco, Mei Zhou, et al.
BMC Emergency Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
COVID-19 outcomes among patients with sickle cell disease or sickle cell trait compared to the general population: a systematic review and meta-analyses
Yachar Dawudi, L. Azoyan, Matthieu Bonjour, et al.
Annals of Hematology (2024) Vol. 103, Iss. 12, pp. 5071-5083
Closed Access | Times Cited: 1
Yachar Dawudi, L. Azoyan, Matthieu Bonjour, et al.
Annals of Hematology (2024) Vol. 103, Iss. 12, pp. 5071-5083
Closed Access | Times Cited: 1
Enhanced IgG immune response to COVID ‐19 vaccination in patients with sickle cell disease
Hirotomo Nakahara, Narayanaiah Cheedarla, Hans Verkerke, et al.
British Journal of Haematology (2023) Vol. 202, Iss. 5, pp. 937-941
Closed Access | Times Cited: 4
Hirotomo Nakahara, Narayanaiah Cheedarla, Hans Verkerke, et al.
British Journal of Haematology (2023) Vol. 202, Iss. 5, pp. 937-941
Closed Access | Times Cited: 4
Hyperhemolysis in a patient with sickle cell disease and recent SARS‐CoV ‐2 infection, with complex auto‐ and alloantibody work‐up, successfully treated with tocilizumab
Christine Fuja, Vishesh Kothary, Timothy Carll, et al.
Transfusion (2022) Vol. 62, Iss. 7, pp. 1446-1451
Open Access | Times Cited: 7
Christine Fuja, Vishesh Kothary, Timothy Carll, et al.
Transfusion (2022) Vol. 62, Iss. 7, pp. 1446-1451
Open Access | Times Cited: 7
Outcomes of COVID ‐19 hospitalizations in patients with sickle cell disease: A nationwide analysis
Nosakhare Paul Ilerhunmwuwa, Lawrence Inyang, Narek Hakobyan, et al.
European Journal Of Haematology (2023) Vol. 111, Iss. 3, pp. 432-440
Closed Access | Times Cited: 3
Nosakhare Paul Ilerhunmwuwa, Lawrence Inyang, Narek Hakobyan, et al.
European Journal Of Haematology (2023) Vol. 111, Iss. 3, pp. 432-440
Closed Access | Times Cited: 3
Accessible Care with High Patient Satisfaction: Telemedicine Use in Sickle Cell Disease
Shu Zhang, Wingel Xue, E. Boorman, et al.
Telemedicine Journal and e-Health (2022) Vol. 29, Iss. 7, pp. 1068-1077
Closed Access | Times Cited: 5
Shu Zhang, Wingel Xue, E. Boorman, et al.
Telemedicine Journal and e-Health (2022) Vol. 29, Iss. 7, pp. 1068-1077
Closed Access | Times Cited: 5
Assessing the Impact of COVID-19 Vaccines on Sickle Cell Anaemia Patients: A Comparative Analysis of Biochemical and Haematological Parameters
Jehad A. Aldali, Badi A. Alotaibi, Hamzah J. Aldali, et al.
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2203-2203
Open Access | Times Cited: 2
Jehad A. Aldali, Badi A. Alotaibi, Hamzah J. Aldali, et al.
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2203-2203
Open Access | Times Cited: 2
Role of Serum Ferritin in Predicting Outcomes of COVID-19 Infection Among Sickle Cell Disease Patients: A Systematic Review and Meta-Analysis
Jun Xin Lee, Wei Keong Chieng, Muhammad Irfan Abdul Jalal, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 4
Jun Xin Lee, Wei Keong Chieng, Muhammad Irfan Abdul Jalal, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 4
Risk Factors for Pediatric Critical COVID-19: A Systematic Review and Meta-Analysis
Camila Aparicio, Zachary Willis, Mari Nakamura, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Camila Aparicio, Zachary Willis, Mari Nakamura, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Description of a national, multi‐center registry of patients with sickle cell disease and SARS‐CoV‐2 infection: Data from the Pediatric COVID‐19 United States Registry
Aleksandra S. Dain, Caroline Diorio, Brian T. Fisher, et al.
Pediatric Blood & Cancer (2024) Vol. 71, Iss. 6
Closed Access
Aleksandra S. Dain, Caroline Diorio, Brian T. Fisher, et al.
Pediatric Blood & Cancer (2024) Vol. 71, Iss. 6
Closed Access
Population characterization of mutations for sickle cell anemia and its treatment: One step towards personalized medicine for the disease
Bernardita Cayupe, Rafael Barra
Andes pediatrica (2024) Vol. 95, Iss. 1, pp. 41-41
Open Access
Bernardita Cayupe, Rafael Barra
Andes pediatrica (2024) Vol. 95, Iss. 1, pp. 41-41
Open Access
Evaluating the effectiveness of COVID-19 vaccines in adults with sickle cell disease during the Omicron period of COVID-19 pandemic
Kim Abbegail Tan Aldecoa, Chef Stan L. Macaraeg, Camelia Arsene, et al.
Frontiers in Hematology (2024) Vol. 3
Open Access
Kim Abbegail Tan Aldecoa, Chef Stan L. Macaraeg, Camelia Arsene, et al.
Frontiers in Hematology (2024) Vol. 3
Open Access
